Drug
Clenil Modulite Via Aerochamber Plus
Clenil Modulite Via Aerochamber Plus: highest development phase Phase 2, developed by Chiesi Farmaceutici. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Chiesi Farmaceutici
Trials
| Drug | Phase | Indication |
|---|---|---|
| Clenil® Modulite® via AeroChamber Plus™ NCT01370031 | Phase 2 | Asthma |
Latest
No recent events.
Follow Clenil Modulite Via Aerochamber Plus on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.